AI Tool Boosts Clinical Trial Success in Cancer, Brain Drugs

A Canadian company's artificial intelligence system helps pharmaceutical researchers identify which patient groups respond best to experimental treatments, potentially saving years of development time.

The FDA-validated technology targets a $10 billion market while improving success rates for notoriously difficult brain and cancer therapies.